How does the pharmaceutical disclosure code affect health care providers?
January 29th 2015 – Hilton, Rotterdam – 9.30-13.15
|ABOUT THE EVENT – AGENDA – REPORT – DOWNLOADS & VIDEO|
EFPIA’s ‘Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations’ has now gone live, with member companies in 33 countries starting to collect data. Representatives of practitioners, patients and the industry met at the end of January to discuss the next steps in implementation.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code has gone live, and from the start of the year member companies have been collating details of all transfers of value to healthcare professionals and healthcare organisations.
While the collection of information is underway, there is still considerable work to be completed in the course of 2015, in order that member companies and national associations are ready to comply with the code.
The most critical element will be getting consent from healthcare providers to disclose their information. With culture, attitudes and degrees of preparedness differing across Europe, EFPIA organised a workshop under the banner of its Responsible Transparency Initiative, bringing together practitioners, patients and industry, to reflect on progress and share best practice.